Soluble CD163 from activated macrophages predicts mortality in acute liver failure
- 1 November 2007
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 47 (5) , 671-676
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*Critical Care Medicine, 2006
- Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsisEuropean Journal of Haematology, 2006
- Biochemical and functional characterization of three activated macrophage populationsJournal of Leukocyte Biology, 2006
- Pivotal Advance: Activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163Journal of Leukocyte Biology, 2006
- Reduced monocyte HLA-DR expression: A novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failureHepatology, 2006
- Gc-Globulin to Predict Outcome in Acute Liver FailureLiver Transplantation, 2005
- Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failureJournal of Gastroenterology, 2005
- Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levelsCytometry Part B: Clinical Cytometry, 2004
- The systemic inflammatory response syndrome in acute liver failureHepatology, 2000
- High Levels of Serum Interleukin‐10 and Tumor Necrosis Factor–α Are Associated with Fatality in Fulminant HepatitisThe Journal of Infectious Diseases, 2000